Todos Medical completes automation equipment installation and training for its Brooklyn lab client

Todos Medical Ltd (OTCQB:TOMDF) announced that it has successfully installed automated lab equipment and completed training for a lab client in Brooklyn, New York.   Todos said the implementation of its automation solution has expanded the lab’s processing capacity to 6,000 polymerase chain reaction (PCR) tests per day from 500 PCR tests per day, with the potential to quickly expand to up to 12,000 PCR tests per day. PCR tests are designed to detect the presence of a virus. “After considerable work helping to complete the installation process, our Brooklyn lab client has successfully completed training and is now able to report PCR testing results utilizing our process,” Todos Medical CEO Gerald Commissiong said in a statement. READ: Todos Medical in the business of saving lives with early disease detection “We are now focused on continuing to serve our lab clients, with a hyper-focus on helping them upgrade their saliva PCR testing capabilities to meet the needs of new testing populations that we expect will be conducting COVID testing for the foreseeable future, such as schools, skilled nursing facilities and sports & entertainment venues,” he added. The company noted the lab will be implementing Emergency Use Authorization (EUA) approved PCR testing for coronavirus (COVID-19), as well as COVID + influenza A & B PCR testing upon request for select clients. Additionally, through the future implementation of pooling, the lab could potentially increase processing capacity to in excess of 40,000 PCR tests per day at a 4:1 ratio. As well, Todos Medical said its automation solution is expected to be instrumental in helping its Brooklyn lab client service a new contract recently entered into with the State of Kentucky to conduct testing for nursing home clients.    It anticipates nursing homes to continue to conduct surveillance testing for COVID-19 for at least the next several years. Headquartered in Rehovot, Israel, Todos Medical engineers life-saving diagnostic solutions for the early detection of a variety of cancers.  The company's state-of-the-art and patented Todos Biochemical Infrared Analyses (TBIA) is a proprietary cancer-screening technology using peripheral blood analysis that deploys deep examination into cancer's influence on the immune system, looking for biochemical changes in blood mononuclear cells and plasma. Todos is also developing blood tests for the early detection of neurodegenerative disorders, such as Alzheimer's disease. Contact Sean at sean@proactiveinvestors.com